ninth virus niv reemerg zoonot pathogen genus henipaviru paramyxovirida family virus ended bangladesh malaysia highly fatal livestock human human case fatal rate current approve vaccine market goal studi use recombin rabe vector express glycoprotein g develop rival candid disease rabbi also signifies health burden region wellestablish strain lack neurovirul stable express foreign antigen immunogen various anim model mouse incl entrants live rabvniv niparab show sign test immunogen group cbl immune intramuscularli single dose partial two dose chemin inactive viral vaccine specify seroconvers inac group yield higher tier antibody furthermore crossreact immune serum genera he confirm immunofluoresc indirect lisa soluble kill vaccine induce neutral result india may use protect possible prevent measure well 